Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease

Focus on obesity, diabetes and cardiovascular diseases

Oh Yoen Kim, Jong Ho Lee, Gary Sweeney

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

There have been considerable improvements in therapeutics for chronic diseases. However, the maximum benefit of these or other options are hard to achieve in practice, due in part to the difficulties associated with determining optimal targets for such interventions. Recent developments have suggested that understanding changes in metabolite profiles will confer a high degree of predictive accuracy in terms of understanding the fundamental mechanisms resulting in perturbations of the metabolic state. Metabolomics involves the establishment of relationships between phenotype and a metabolic signature, which are key aspects of biological function. These approaches have been applied to the identification of serum/plasma metabolic markers involved in obesity, diabetes and vascular disease using animal models or in humans. Different kinds of metabolite profiling techniques using nuclear magnetic resonance spectroscopy, mass spectrometry, ultraperformance liquid chromatography and so on are currently employed to generate global metabolic profiles. Scientific information derived from these techniques can be applied to provide accurate and clinically useful prognostic/diagnostic capability for the management of major chronic diseases. One current consideration limiting the widespread use of metabolomic profiling is the analysis of its cost-effectiveness. In summary, it is hoped that the information derived from metabolite profiling will make it possible to suggest individualized therapies that more effectively treat disease.

Original languageEnglish
Pages (from-to)61-68
Number of pages8
JournalExpert Review of Cardiovascular Therapy
Volume11
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Metabolomics
Chronic Disease
Cardiovascular Diseases
Obesity
Metabolome
Vascular Diseases
Liquid Chromatography
Cost-Benefit Analysis
Mass Spectrometry
Magnetic Resonance Spectroscopy
Animal Models
Phenotype
Therapeutics
Serum

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

@article{046cea213cca4ddaaea79ed84b4e81bc,
title = "Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease: Focus on obesity, diabetes and cardiovascular diseases",
abstract = "There have been considerable improvements in therapeutics for chronic diseases. However, the maximum benefit of these or other options are hard to achieve in practice, due in part to the difficulties associated with determining optimal targets for such interventions. Recent developments have suggested that understanding changes in metabolite profiles will confer a high degree of predictive accuracy in terms of understanding the fundamental mechanisms resulting in perturbations of the metabolic state. Metabolomics involves the establishment of relationships between phenotype and a metabolic signature, which are key aspects of biological function. These approaches have been applied to the identification of serum/plasma metabolic markers involved in obesity, diabetes and vascular disease using animal models or in humans. Different kinds of metabolite profiling techniques using nuclear magnetic resonance spectroscopy, mass spectrometry, ultraperformance liquid chromatography and so on are currently employed to generate global metabolic profiles. Scientific information derived from these techniques can be applied to provide accurate and clinically useful prognostic/diagnostic capability for the management of major chronic diseases. One current consideration limiting the widespread use of metabolomic profiling is the analysis of its cost-effectiveness. In summary, it is hoped that the information derived from metabolite profiling will make it possible to suggest individualized therapies that more effectively treat disease.",
author = "Kim, {Oh Yoen} and Lee, {Jong Ho} and Gary Sweeney",
year = "2013",
month = "1",
day = "1",
doi = "10.1586/erc.12.121",
language = "English",
volume = "11",
pages = "61--68",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "1",

}

Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease : Focus on obesity, diabetes and cardiovascular diseases. / Kim, Oh Yoen; Lee, Jong Ho; Sweeney, Gary.

In: Expert Review of Cardiovascular Therapy, Vol. 11, No. 1, 01.01.2013, p. 61-68.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease

T2 - Focus on obesity, diabetes and cardiovascular diseases

AU - Kim, Oh Yoen

AU - Lee, Jong Ho

AU - Sweeney, Gary

PY - 2013/1/1

Y1 - 2013/1/1

N2 - There have been considerable improvements in therapeutics for chronic diseases. However, the maximum benefit of these or other options are hard to achieve in practice, due in part to the difficulties associated with determining optimal targets for such interventions. Recent developments have suggested that understanding changes in metabolite profiles will confer a high degree of predictive accuracy in terms of understanding the fundamental mechanisms resulting in perturbations of the metabolic state. Metabolomics involves the establishment of relationships between phenotype and a metabolic signature, which are key aspects of biological function. These approaches have been applied to the identification of serum/plasma metabolic markers involved in obesity, diabetes and vascular disease using animal models or in humans. Different kinds of metabolite profiling techniques using nuclear magnetic resonance spectroscopy, mass spectrometry, ultraperformance liquid chromatography and so on are currently employed to generate global metabolic profiles. Scientific information derived from these techniques can be applied to provide accurate and clinically useful prognostic/diagnostic capability for the management of major chronic diseases. One current consideration limiting the widespread use of metabolomic profiling is the analysis of its cost-effectiveness. In summary, it is hoped that the information derived from metabolite profiling will make it possible to suggest individualized therapies that more effectively treat disease.

AB - There have been considerable improvements in therapeutics for chronic diseases. However, the maximum benefit of these or other options are hard to achieve in practice, due in part to the difficulties associated with determining optimal targets for such interventions. Recent developments have suggested that understanding changes in metabolite profiles will confer a high degree of predictive accuracy in terms of understanding the fundamental mechanisms resulting in perturbations of the metabolic state. Metabolomics involves the establishment of relationships between phenotype and a metabolic signature, which are key aspects of biological function. These approaches have been applied to the identification of serum/plasma metabolic markers involved in obesity, diabetes and vascular disease using animal models or in humans. Different kinds of metabolite profiling techniques using nuclear magnetic resonance spectroscopy, mass spectrometry, ultraperformance liquid chromatography and so on are currently employed to generate global metabolic profiles. Scientific information derived from these techniques can be applied to provide accurate and clinically useful prognostic/diagnostic capability for the management of major chronic diseases. One current consideration limiting the widespread use of metabolomic profiling is the analysis of its cost-effectiveness. In summary, it is hoped that the information derived from metabolite profiling will make it possible to suggest individualized therapies that more effectively treat disease.

UR - http://www.scopus.com/inward/record.url?scp=84871579721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871579721&partnerID=8YFLogxK

U2 - 10.1586/erc.12.121

DO - 10.1586/erc.12.121

M3 - Review article

VL - 11

SP - 61

EP - 68

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 1

ER -